Skip to main content
Erschienen in: Surgery Today 6/2021

23.01.2021 | Original Article

Surgical treatment for secondary spontaneous pneumothorax: a risk factor analysis

verfasst von: Norikazu Kawai, Takeshi Kawaguchi, Motoaki Yasukawa, Takashi Tojo, Noriyoshi Sawabata, Shigeki Taniguchi

Erschienen in: Surgery Today | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

While surgery is an effective treatment for secondary spontaneous pneumothorax (SSP), it can be difficult, because affected patients are usually in a poor general condition. The present study investigated the risk factors of postoperative complications after surgery for SSP.

Methods

Eighty-eight patients with SSP who underwent surgery from January 2006 to March 2018 were investigated. Clinical data were reviewed, and a multivariate analysis was performed.

Results

Eighty-four patients (95%) were males, and the median patient age was 72 years. Underlying lung diseases were chronic obstructive pulmonary disease in 58 patients (65.9%), interstitial pneumonia in 26 (29.5%), and others in 4 (4.5%). Postoperative complications developed in 21 patients (24%). Hospital mortality/prolonged length of stay occurred in 6 patients (7%). A multivariate analysis showed that the preoperative performance status (performance status 0–2 vs. 3, hazard ratio: 6.570, 95% confidence interval: 1.980–21.800) was an independent predictor of postoperative complications.

Conclusion

Surgery for SSP contributed to early chest tube removal and favorable outcomes. However, rare fatal events occurred, and the patient performance status was a risk factor for postoperative complications. A careful evaluation of each patient’s performance status is needed to determine the need for surgical intervention for SSP.
Literatur
1.
Zurück zum Zitat MacDuff A, Arnold A, Harvey J. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii18-31.CrossRef MacDuff A, Arnold A, Harvey J. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii18-31.CrossRef
2.
Zurück zum Zitat Sahn SA, Heffner JE. Spontaneous pneumothorax. N Engl J Med. 2000;342:868–74.CrossRef Sahn SA, Heffner JE. Spontaneous pneumothorax. N Engl J Med. 2000;342:868–74.CrossRef
3.
Zurück zum Zitat Ueda Y, Osada H, Osugi H. Thoracic and cardiovascular surgery in Japan during 2005. Gen Thorac Cardiovasc Surg. 2007;55:377–99.CrossRef Ueda Y, Osada H, Osugi H. Thoracic and cardiovascular surgery in Japan during 2005. Gen Thorac Cardiovasc Surg. 2007;55:377–99.CrossRef
4.
Zurück zum Zitat Shimizu H, Endo S, Natsugoe S, Doki Y, Hirata Y, Kobayashi J, et al. Thoracic and cardiovascular surgery in Japan in 2016. Gen Thorac Cardiovasc Surg. 2019;67:377–411.CrossRef Shimizu H, Endo S, Natsugoe S, Doki Y, Hirata Y, Kobayashi J, et al. Thoracic and cardiovascular surgery in Japan in 2016. Gen Thorac Cardiovasc Surg. 2019;67:377–411.CrossRef
5.
Zurück zum Zitat Baumann MH, Strange C, Heffner JE, Light L, Kirby TJ, Klein J, et al. Management of spontaneous pneumothorax. Chest. 2001;119:590–602.CrossRef Baumann MH, Strange C, Heffner JE, Light L, Kirby TJ, Klein J, et al. Management of spontaneous pneumothorax. Chest. 2001;119:590–602.CrossRef
6.
Zurück zum Zitat Hence JM, Martin JT, Mullett TW. Endobronchial valves in the treatment of persistent air leaks. Ann Thorac Surg. 2015;100:1780–6.CrossRef Hence JM, Martin JT, Mullett TW. Endobronchial valves in the treatment of persistent air leaks. Ann Thorac Surg. 2015;100:1780–6.CrossRef
7.
Zurück zum Zitat Kanda H, Minami K, Nakano T, Taniguchi Y, Saito T, Konobu T, et al. Efficacy and long-term clinical outcome of bronchial occlusion with endobronchial Watanabe spigots for persistent air leaks. Respir Investig. 2015;53:30–6.CrossRef Kanda H, Minami K, Nakano T, Taniguchi Y, Saito T, Konobu T, et al. Efficacy and long-term clinical outcome of bronchial occlusion with endobronchial Watanabe spigots for persistent air leaks. Respir Investig. 2015;53:30–6.CrossRef
8.
Zurück zum Zitat Kurihara M, Kataoka H, Ishikawa A, Endo R. Latest treatments for spontaneous pneumothorax. Gen Thorac Cardiovasc Surg. 2010;58:113–9.CrossRef Kurihara M, Kataoka H, Ishikawa A, Endo R. Latest treatments for spontaneous pneumothorax. Gen Thorac Cardiovasc Surg. 2010;58:113–9.CrossRef
9.
Zurück zum Zitat Saito Y, Suzuki Y, Demura R, Kawai H. The outcome and risk factors for recurrence and extended hospitalization of secondary spontaneous pneumothorax. Surg Today. 2018;48:320–4.CrossRef Saito Y, Suzuki Y, Demura R, Kawai H. The outcome and risk factors for recurrence and extended hospitalization of secondary spontaneous pneumothorax. Surg Today. 2018;48:320–4.CrossRef
10.
Zurück zum Zitat Ichinose J, Nagayama K, Hino H, Nitadori J, Anraku M, Murakawa T, et al. Results of surgical treatment for secondary spontaneous pneumothorax according to underlying disease. Eur J Cardiothorac Surg. 2016;49:1132–6.CrossRef Ichinose J, Nagayama K, Hino H, Nitadori J, Anraku M, Murakawa T, et al. Results of surgical treatment for secondary spontaneous pneumothorax according to underlying disease. Eur J Cardiothorac Surg. 2016;49:1132–6.CrossRef
11.
Zurück zum Zitat Igai H, Kamiyoshihara M, Ibe T, Kawatani N, Shimizu K. Surgical treatment for elderly patients with secondary spontaneous pneumothorax. Gen Thorac Cardiovasc Surg. 2016;64:267–72.CrossRef Igai H, Kamiyoshihara M, Ibe T, Kawatani N, Shimizu K. Surgical treatment for elderly patients with secondary spontaneous pneumothorax. Gen Thorac Cardiovasc Surg. 2016;64:267–72.CrossRef
12.
Zurück zum Zitat Isaka M, Asai K, Urabe N. Surgery for secondary spontaneous pneumothorax: risk factors for recurrence and morbidity. Interact CardioVasc Thorac Surg. 2013;17:247–52.CrossRef Isaka M, Asai K, Urabe N. Surgery for secondary spontaneous pneumothorax: risk factors for recurrence and morbidity. Interact CardioVasc Thorac Surg. 2013;17:247–52.CrossRef
13.
Zurück zum Zitat Shaikhrezai K, Thompson AI, Parkin C, Stamenkovic S, Walker WS. Video-assisted thoracoscopic surgery management of spontaneous pneumothorax-long-term results. Eur J Cardiothorac Surg. 2011;40:120–3.CrossRef Shaikhrezai K, Thompson AI, Parkin C, Stamenkovic S, Walker WS. Video-assisted thoracoscopic surgery management of spontaneous pneumothorax-long-term results. Eur J Cardiothorac Surg. 2011;40:120–3.CrossRef
14.
Zurück zum Zitat Clavein PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavein-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef Clavein PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavein-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef
15.
Zurück zum Zitat Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef
16.
Zurück zum Zitat Porcel JM. Secondary spontaneous pneumothorax in idiopathic pulmonary fibrosis: Grim news. Respirology. 2018;23:448–9.CrossRef Porcel JM. Secondary spontaneous pneumothorax in idiopathic pulmonary fibrosis: Grim news. Respirology. 2018;23:448–9.CrossRef
17.
Zurück zum Zitat Nishimoto K, Fujisawa T, Yoshimura K, Enomoto Y, Enomoto N, Nakamura Y, et al. The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis. Respirology. 2018;23:519–25.CrossRef Nishimoto K, Fujisawa T, Yoshimura K, Enomoto Y, Enomoto N, Nakamura Y, et al. The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis. Respirology. 2018;23:519–25.CrossRef
18.
Zurück zum Zitat Watanabe T, Fukai I, Okuda K, Moriyama S, Haneda H, Kawano O, et al. Talc pleurodesis for secondary pneumothorax in elderly patients with persistent air leak. J Thorac Dis. 2019;11:171–6.CrossRef Watanabe T, Fukai I, Okuda K, Moriyama S, Haneda H, Kawano O, et al. Talc pleurodesis for secondary pneumothorax in elderly patients with persistent air leak. J Thorac Dis. 2019;11:171–6.CrossRef
19.
Zurück zum Zitat Qin SL, Huang JB, Yang YL, Xian L. Uniportal versus three-port video-assisted thoracoscopic surgery for spontaneous pneumothorax: a meta-analysis. J Thorac Dis. 2015;7:2274–87.PubMedPubMedCentral Qin SL, Huang JB, Yang YL, Xian L. Uniportal versus three-port video-assisted thoracoscopic surgery for spontaneous pneumothorax: a meta-analysis. J Thorac Dis. 2015;7:2274–87.PubMedPubMedCentral
20.
Zurück zum Zitat Yasuda M, Nakanishi R, Mori M, Ashikari S, Oyama T, Hanagiri T. Simple covering technique in thoracoscopic bullectomy for spontaneous pneumothorax. J Thorac Dis. 2017;9:4584–8.CrossRef Yasuda M, Nakanishi R, Mori M, Ashikari S, Oyama T, Hanagiri T. Simple covering technique in thoracoscopic bullectomy for spontaneous pneumothorax. J Thorac Dis. 2017;9:4584–8.CrossRef
21.
Zurück zum Zitat Deguchi H, Tomoyasu M, Shigeeda W, Kaneko Y, Kanno H, Saito H. Reduction for air leakage using linear staple device with bioabsorbable polyglycolic acid felt for pulmonary lobectomy. Gen Thorac Cardiovasc Surg. 2020;68:266–72.CrossRef Deguchi H, Tomoyasu M, Shigeeda W, Kaneko Y, Kanno H, Saito H. Reduction for air leakage using linear staple device with bioabsorbable polyglycolic acid felt for pulmonary lobectomy. Gen Thorac Cardiovasc Surg. 2020;68:266–72.CrossRef
23.
Zurück zum Zitat Merchea A, Abdelsattar ZM, Taner T, Dean PG, Colibaseanu DT, Larson DW, et al. Outcomes of colorectal cancer arising in solid organ transplant recipients. J Gastrontest Surg. 2014;18:599–604.CrossRef Merchea A, Abdelsattar ZM, Taner T, Dean PG, Colibaseanu DT, Larson DW, et al. Outcomes of colorectal cancer arising in solid organ transplant recipients. J Gastrontest Surg. 2014;18:599–604.CrossRef
24.
Zurück zum Zitat Krantz SB, Mitzman B, Lutfi W, Kuchta K, Wang CH, Howington JA, et al. Neoadjuvant chemoradiation shows no survival advantage to chemotherapy alone in stage IIIA patients. Ann Thorac Surg. 2018;105:1008–16.CrossRef Krantz SB, Mitzman B, Lutfi W, Kuchta K, Wang CH, Howington JA, et al. Neoadjuvant chemoradiation shows no survival advantage to chemotherapy alone in stage IIIA patients. Ann Thorac Surg. 2018;105:1008–16.CrossRef
25.
Zurück zum Zitat Elsayed HH, Hassaballa A, Ahmed T. Is video-assisted thoracoscopic surgery talc pleurodesis superior to talc pleurodesis via tube thoracostomy in patients with secondary spontaneous pneumothorax? Interact CardioVasc Thorac Surg. 2016;23:459–61.CrossRef Elsayed HH, Hassaballa A, Ahmed T. Is video-assisted thoracoscopic surgery talc pleurodesis superior to talc pleurodesis via tube thoracostomy in patients with secondary spontaneous pneumothorax? Interact CardioVasc Thorac Surg. 2016;23:459–61.CrossRef
26.
Zurück zum Zitat Kawachi R, Matsuwaki R, Tachibana K, Karita S, Nakazato Y, Tanaka R, et al. Thoracoscopic modified pleural tent for spontaneous pneumothorax. Interact CardioVasc Thorac Surg. 2016;23:190–5.CrossRef Kawachi R, Matsuwaki R, Tachibana K, Karita S, Nakazato Y, Tanaka R, et al. Thoracoscopic modified pleural tent for spontaneous pneumothorax. Interact CardioVasc Thorac Surg. 2016;23:190–5.CrossRef
27.
Zurück zum Zitat Chang CC, Chen YY, Chang JM, Tseng YL, Lin CY, Chuang MT, et al. Pleural tenting as an effective adjunct in patients with pneumothorax secondary to emphysema evaluated with computed tomography scan. J Thorac Dis. 2016;8:S652–8.CrossRef Chang CC, Chen YY, Chang JM, Tseng YL, Lin CY, Chuang MT, et al. Pleural tenting as an effective adjunct in patients with pneumothorax secondary to emphysema evaluated with computed tomography scan. J Thorac Dis. 2016;8:S652–8.CrossRef
Metadaten
Titel
Surgical treatment for secondary spontaneous pneumothorax: a risk factor analysis
verfasst von
Norikazu Kawai
Takeshi Kawaguchi
Motoaki Yasukawa
Takashi Tojo
Noriyoshi Sawabata
Shigeki Taniguchi
Publikationsdatum
23.01.2021
Verlag
Springer Singapore
Erschienen in
Surgery Today / Ausgabe 6/2021
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-020-02206-0

Weitere Artikel der Ausgabe 6/2021

Surgery Today 6/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.